Clinical Trial Update: Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders [Phase 1]

View source ↗

Summary

Phase 1 trial update on T-allo10 for hematopoietic stem cell transplantation in various blood disorders; the NCT03198234 study sponsored by Maria Grazia Roncaro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Hodgkin Lymphoma
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• T-allo10

Snippet

Sponsor: Roncarolo, Maria Grazia, MD | Conditions: AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome) | Phase 1 | Status: TERMINATED | Results posted: 2024-07-18